This inventor holds 4 USPTO granted patents. Top assignee: Case Western Reserve University. Active years: 1999-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cleveland, OH (US) (1999 - 2005)
- Monmouth Junction, NJ (US) (2006)
Company Filing History:
Years Active: 1999-2006
Title: The Innovations of David H. Gorski
Introduction
David H. Gorski is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of biomedical research, particularly in the study of vascular smooth muscle cell proliferation. With a total of 4 patents to his name, Gorski's work has implications for the treatment of blood vessel diseases.
Latest Patents
One of Gorski's latest patents involves the discovery of a novel growth arrest homeobox gene. This gene, referred to as the 'Gax gene', has been identified in both rat and human nucleotide sequences. The expression of the Gax gene inhibits the growth of vascular smooth muscle cells. This discovery is particularly relevant for understanding and treating conditions that arise from excessive smooth muscle cell proliferation, especially following procedures like balloon angioplasty.
Career Highlights
Gorski is affiliated with Case Western Reserve University, where he conducts his research. His work has garnered attention for its potential applications in medical treatments and therapies. His innovative approach to understanding vascular biology has positioned him as a key figure in his field.
Collaborations
Gorski collaborates with Kenneth Walsh, a fellow researcher, to further explore the implications of their findings in vascular biology. Their partnership enhances the depth and breadth of their research endeavors.
Conclusion
David H. Gorski's contributions to the field of biomedical research, particularly through his patents related to the Gax gene, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of vascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
